Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture. (July 2021)
- Record Type:
- Journal Article
- Title:
- Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture. (July 2021)
- Main Title:
- Test-based de-isolation in COVID-19 immunocompromised patients: Cycle threshold value versus SARS-CoV-2 viral culture
- Authors:
- Alshukairi, Abeer N.
Tolah, Ahmed M.
Dada, Ashraf
Al-Tawfiq, Jaffar A.
Almagharbi, Reem S.
Saeedi, Mohammed F.
Al-Hamzi, Mohammed A.
El-Kafrawy, Sherif A.
Bahaudden, Husam A.
El-Saed, Aiman
Al-Mozaini, Maha A.
Khalid, Imran
Hefni, Lama K.
Hassan, Ahmed M.
Alandijany, Thamir A.
Bajrai, Leena H.
Bayumi, Daniyah T.
Albishi, Ghadeer E.
Althawadi, Sahar I.
Zabani, Najla A.
Perlman, Stanley
Azhar, Esam I. - Abstract:
- Highlights: The de-isolation of immunocompromised COVID-19 patients is challenging. A test-based rather than symptom-based approach is suggested. The mean Ct value for negative viral cultures was 20.5 in this case series. A test-based approach could lead to prolonged quarantine of non-infectious patients. The de-isolation of immunocompromised patients needs disease-specific studies. Abstract: Background: Immunocompromised patients with coronavirus disease 2019 (COVID-19) have prolonged infectious viral shedding for more than 20 days. A test-based approach is suggested for de-isolation of these patients. Methods: The strategy was evaluated by comparing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (cycle threshold (Ct) values) and viral culture at the time of hospital discharge in a series of 13 COVID-19 patients: six immunocompetent and seven immunocompromised (five solid organ transplant patients, one lymphoma patient, and one hepatocellular carcinoma patient). Results: Three of the 13 (23%) patients had positive viral cultures: one patient with lymphoma (on day 16) and two immunocompetent patients (on day 7 and day 11). Eighty percent of the patients had negative viral cultures and had a mean Ct value of 20.5. None of the solid organ transplant recipients had positive viral cultures. Conclusions: The mean Ct value for negative viral cultures was 20.5 in this case series of immunocompromised patients. Unlike those with hematological malignancies,Highlights: The de-isolation of immunocompromised COVID-19 patients is challenging. A test-based rather than symptom-based approach is suggested. The mean Ct value for negative viral cultures was 20.5 in this case series. A test-based approach could lead to prolonged quarantine of non-infectious patients. The de-isolation of immunocompromised patients needs disease-specific studies. Abstract: Background: Immunocompromised patients with coronavirus disease 2019 (COVID-19) have prolonged infectious viral shedding for more than 20 days. A test-based approach is suggested for de-isolation of these patients. Methods: The strategy was evaluated by comparing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) viral load (cycle threshold (Ct) values) and viral culture at the time of hospital discharge in a series of 13 COVID-19 patients: six immunocompetent and seven immunocompromised (five solid organ transplant patients, one lymphoma patient, and one hepatocellular carcinoma patient). Results: Three of the 13 (23%) patients had positive viral cultures: one patient with lymphoma (on day 16) and two immunocompetent patients (on day 7 and day 11). Eighty percent of the patients had negative viral cultures and had a mean Ct value of 20.5. None of the solid organ transplant recipients had positive viral cultures. Conclusions: The mean Ct value for negative viral cultures was 20.5 in this case series of immunocompromised patients. Unlike those with hematological malignancies, none of the solid organ transplant patients had positive viral cultures. Adopting the test-based approach for all immunocompromised patients may lead to prolonged quarantine. Large-scale studies in disease-specific populations are needed to determine whether a test-based approach versus a symptom-based approach or a combination is applicable for the de-isolation of various immunocompromised patients. … (more)
- Is Part Of:
- International journal of infectious diseases. Volume 108(2021)
- Journal:
- International journal of infectious diseases
- Issue:
- Volume 108(2021)
- Issue Display:
- Volume 108, Issue 2021 (2021)
- Year:
- 2021
- Volume:
- 108
- Issue:
- 2021
- Issue Sort Value:
- 2021-0108-2021-0000
- Page Start:
- 112
- Page End:
- 115
- Publication Date:
- 2021-07
- Subjects:
- SARS-CoV-2 -- Viral culture -- Isolation -- Immunocompromised patients
Communicable diseases -- Periodicals
Communicable Diseases -- Periodicals
Communicable diseases
Periodicals
Electronic journals
616.9 - Journal URLs:
- http://bibpurl.oclc.org/web/73769 ↗
http://www.journals.elsevier.com/international-journal-of-infectious-diseases/ ↗
http://www.sciencedirect.com/science/journal/12019712 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/12019712 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/12019712 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.ijid.2021.05.027 ↗
- Languages:
- English
- ISSNs:
- 1201-9712
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.304750
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 17594.xml